White Mark Andrew
SEC CIK 1973240 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | See Remarks | 69.1K | — | $421.7K | 5 | 2023-04-04 | 2024-10-31 |
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
White Mark Andrew made no open-market trades at RCKT in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-04 | 2024-10-31 | RCKT | ROCKET PHARMACEUTICALS, INC. | White Mark Andrew | See Remarks | S - Sale | $16.63 | -3,080 | 69.1K | -4% | -$51.2K | |
| 2024-07-09 | 2024-07-08 | RCKT | ROCKET PHARMACEUTICALS, INC. | White Mark Andrew | See Remarks | S - Sale | $20.40 | -3,026 | 72.2K | -4% | -$61.7K | |
| 2024-04-10 | 2024-04-08 | RCKT | ROCKET PHARMACEUTICALS, INC. | White Mark Andrew | See Remarks | S - Sale | $24.64 | -12.5K | 75.2K | -14% | -$308.8K | |
| D | 2024-02-21 | 2024-02-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | White Mark Andrew | Chief Medical Off | A - Grant | $0.00 | +11.1K | 87.8K | +14% | $0 |
| D | 2023-04-12 | 2023-04-04 | RCKT | ROCKET PHARMACEUTICALS, INC. | White Mark Andrew | Chief Medical Off | A - Grant | $0.00 | +76.7K | 76.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations